An emerging concept in gene expression regulation is that a diverse set of modified nucleotides is found internally within mRNA, and these modifications constitute an epitranscriptomic code. The initial concept of the epitranscriptome was introduced with the transcriptome-wide mapping of N 6 -methyladenosine (m 6 A), which revealed that m 6 A is found in at least a fourth of all mRNAs, typically near stop codons 1,2 . Notably, adenosine methylation to form m 6 A may be reversible. FTO and AlkB family member 5 (ALKBH5) both show demethylation acti vity towards RNA containing m 6 A (refs 3,4). Thus, the epitranscriptome may be highly dynamic and subject to reversible base modifications that influence mRNA function.
A is found in at least a fourth of all mRNAs, typically near stop codons 1, 2 . Notably, adenosine methylation to form m 6 A may be reversible. FTO and AlkB family member 5 (ALKBH5) both show demethylation acti vity towards RNA containing m 6 A (refs 3,4). Thus, the epitranscriptome may be highly dynamic and subject to reversible base modifications that influence mRNA function.
In addition to internal base modifications, the 5′ end of mRNAs contains methyl modifications that are thought to be constitutive. mRNA biogenesis involves the addition of an N 7 -methylguanosine (m 7 G) cap with a triphosphate linker to the 5′ end of mRNAs. mRNAs are also methylated at the 2′-hydroxyl position of the ribose sugar of the first, and sometimes the second, nucleotide adjacent to the m 7 G cap 5, 6 . These modifications recruit translation initiation factors to mRNA and allow the cell to discriminate host from viral mRNA 7 . Although the extended 5′ cap structure contains these fixed methyl modifications, early studies by Moss and colleagues showed that one additional methyl modification can be detected in up to 30% of mRNA caps A m is unknown. Here we show that the extended mRNA cap carries dynamic and reversible epitranscriptomic information. We find that m 6 A m in its physiological context adjacent to the m 7 G cap can be readily converted to A m by FTO in vitro and in vivo. Furthermore, we demonstrate that m 6 A m , and not m 6 A, is the preferred cellular substrate for FTO. Using our transcriptome-wide map of m 6 A m , we find that m 6 A m transcripts are markedly more stable than mRNAs beginning with A m or other nucleotides. Manipulation of m 6 A m levels by FTO depletion or FTO overexpression results in selective control of the abundance of m 6 A m -containing mRNAs in cells. We find that m 6 A m transcript stability is in part due to resistance to the mRNA-decapping enzyme DCP2. The significance of m 6 A m -mediated mRNA stabilization can be seen by examining DCP2-dependent mRNA degradation processes in cells, such as the pattern of mRNA degradation induced by microRNAs. These findings show that the cap-associated modified nucleotide m 6 A m is a dynamic and reversible epitranscriptomic modification that confers stability to mRNA in mammalian cells.
FTO targets methyladenine at transcription start sites
FTO exhibits demethylation activity towards m 6 A in assays performed in vitro 4 . However, we previously observed that most m 6 A residues are unaffected in FTO-deficient mice 11 . Only a few m 6 A residues showed increased abundance based on our transcriptome-wide mapping using antibodies directed against N 6 -methyladenine (6mA) 11 . To understand this selectivity, we asked if FTO demethylates m 6 A residues based on their position within mRNAs. We measured the change in m 6 A stoichio metry for each m 6 A peak mapped in the Fto-knockout relative to the wild-type transcriptome. We used a previously described stoichiometry measurement in which the number of m 6 A-containing RNA fragments at each peak is normalized to transcript abundance 1 . Notably, the m 6 A stoichiometry in the Fto-knockout transcriptome was increased for m 6 A residues closer to the 5′ end of the transcript (Extended Data Fig. 1a) .
We recently showed that the antibodies used in these early m A demethylation was not readily detected (Fig. 1c) .
Demethylation of m 6 A was only readily detected using higher concentrations of FTO (200 nM), consistent with previous reports which used a 5:1 ratio of substrate and enzyme 4 . However, demethylation of m 6 A m was achieved with substantially less FTO (20 nM) (Fig. 1d, Extended Data Figs 1c-g ). The reported k cat of FTO towards m 6 A is relatively low compared to related dioxygenases (Extended Data Table 1 ). However, the k cat for FTO towards m 6 A m is at least 20 times higher and the catalytic efficiency (k cat /K m ) of FTO is approximately 100-fold higher towards m 6 A m than m 6 A ( Fig. 1d , Extended Data Table 1 ).
The activity of FTO towards m A was poor in diverse sequence contexts (Extended Data  Fig. 2a, b) .
Mass spectrometry confirmed FTO-mediated demethylation of m 6 A m to A m (Extended Data Fig. 2c, d ). However, in addition to A m , N 6 -hydroxymethyl,2′-O-methyladenosine (hm 6 A m ) was also detected. Previous analysis of FTO activity towards m 6 A showed that FTO-mediated demethylation occurs via a hydroxymethylated intermediate G cap was enzymatically removed from mRNA and the exposed 5′ nucleotide was radiolabelled with [γ-32 P]-ATP. Two-dimensional TLC of the nucleotide hydrolysate reveals the identity of the 5′ nucleotide (Extended Data Fig. 3a) 14 . Treatment of cellular mRNA with recombinant FTO resulted in an approximately 80% reduction of the m 6 A m :A m ratio (Fig. 2a) . Notably, the same mRNA samples did not show decreased m 6 A upon FTO treatment (Extended Data Fig. 3b ). These results suggest that FTO does not efficiently demethylate m A m :A m ratio relative to control cells (Fig. 2b) . Although FTO 
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is primarily nuclear, hypothalamic neurons exhibit cytosolic FTO after food deprivation 15 . Since there is no reported approach to efficiently induce cytosolic localization of FTO in cultured cells, we expressed FTO containing a nuclear-export signal (NES-FTO) in HEK293T cells (Extended Data Fig. 3c, d ). This resulted in a more pronounced drop in the m Table 2) .
We next asked whether mRNA stability is linked to the identity of the first nucleotide. mRNAs beginning with A m , C m , G m and U m exhibited a very similar distribution of half-lives, with an average of around 6 h in HEK293T cells (Fig. 3a) . However, mRNAs that begin with an m 6 A m were markedly more stable, with an average increase in half-life of approximately 2.5 h (Fig. 3a, Extended Data Fig. 5c (Fig. 3b) . Although the increased expression levels could be influenced by transcription rates, the half-life data suggests that increased mRNA stability contributes to the increased abundance of m 6 A m mRNAs. Taken together, these data indicate that the first nucleotide is an important determinant of mRNA stability and abundance.
Additionally, m 6 A m mRNAs may increase translation efficiency (Extended Data Figs 6a-f ). This is in line with a previous study that observed increased translation efficiency of mRNAs containing methylated adenine at the transcription start site A m in vitro. Electroporation of these mRNAs into HEK293T cells showed that the m 6 A m mRNA was more stable than the A minitiated mRNA (Extended Data Fig. 7a) .
Next, we selectively reduced cellular m 6 A m levels by expressing NES-FTO and monitored mRNA half-life. At the level of transfection used, changes in m 6 A were not detectable, but m 6 A m levels were significantly reduced (Extended Data Fig. 3c-f) . Analysis of transcriptome-wide fold-changes in mRNA half-lives showed that NES-FTO expression causes a significant decrease in m 6 A m mRNA half-life compared to mRNAs initiated with A m (Fig. 3c) . m 6 Acontaining mRNAs were unaffected (Extended Data Fig. 7b ). The effect of NES-FTO on m 6 A m mRNAs was also seen when monitoring the stability of individual transcripts using BrU pulse-chase labelling (Extended Data Fig. 7c ). These results suggest that demethylation of m 6 A m reduces the stability of mRNAs that begin with this nucleotide.
Although m 6 A m levels are typically high in most cell types 8, 14 , we further increased m 6 A m levels by FTO knockdown and measured mRNA levels using RNA-seq. Notably, mRNAs that start with m 6 A m showed higher abundance after FTO knockdown compared to A m -initiated mRNAs (Fig. 3d) . This effect was also seen in Fto-knockout mouse liver compared to wild type (Extended Data Fig. 7d) . Notably, ALKBH5 knockdown did not affect m 6 A m mRNAs (Extended Data Fig. 7e ). We therefore conclude that increasing m 6 A m levels enhances the stability of these mRNAs. A m mRNAs were less affected, indicating that they are less susceptible to DCP2-dependent degradation (Fig. 4c) . As an additional control, we monitored the stability of individual mRNAs using BrU pulse-chase labelling. Notably, A m mRNAs showed stabilization upon DCP2 depletion, while m 6 A m mRNAs were not significantly stabilized (Extended Data Fig. 8c ). These results suggest that m 6 A m confers resistance to DCP2, resulting in increased mRNA stability. A m also probably contributes to this effect owing to its sensitivity to FTO. FTO-deficient mice display diverse phenotypes ranging from growth retardation to metabolic changes and abnormalities in brain reward pathways 11, 27 . Humans with FTO loss-of-function mutations exhibit growth retardation and malformations A residues in the 5′ UTR are linked to increased translation 23 , suggesting that these different methylated forms of adenosine in the 5′ UTR enhance translation initiation. Thus, the location of the modified nucleotide and the specific combination of methyl groups on adenosine residues encode distinct functional consequences on the mRNA.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. Supplementary Information is available in the online version of the paper.

METHODS
No statistical methods were used to predetermine sample size. The experiments were not randomized and the investigators were not blinded to allocation during experiments and outcome assessment. Synthesis and characterization of synthetic oligonucleotides. The sequences of all the oligonucleotides used in this study are shown in Supplementary Table 4 , they were obtained with high purity (>95%) and they were unambiguously characterized by MALDI-TOF spectrometry (Supplementary Table 4) . , with the exception that all reactions were carried out at 37 °C. The demethylation activity assay was performed in 20-50 μl of reaction mixture containing the indicated quantities of synthetic RNA oligonucleotide or mRNA, the indicated quantities of FTO, 75 mM of (NH 4 ) 2 Fe(SO 4 ) 2 , 300 mM α-ketoglutarate, 2 mM sodium l-ascorbate, 150 mM KCl and 50 mM HEPES buffer, pH 7.0. The reaction was incubated at 37 °C for the indicated times, quenched by the addition of 1 mM of EDTA followed by inactivation of the enzymes for 5 min at 95 °C. Sample preparation for HPLC analysis. After demethylation by FTO, oligonucleotides were decapped with 25 units of RppH (NEB) in ThermoPol buffer for 2 h at 37 °C. RNA was subsequently digested to single nucleotides with 180 units of S1 nuclease (Takara) for 1 h at 37 °C. 5′ phosphates were removed with 5 units of rSAP (NEB) for 1 h at 37 °C. Before loading the samples onto the HPLC column, proteins were removed by size-exclusion chromatography with a 10 kDa cut-off filter (VWR). HPLC analysis of demethylation activity. The HPLC analysis of nucleosides was performed on an Agilent 1100 system (Agilent Technologies). Separation was performed on a Poroshell 120 EC-C18 column (4 μm, 150 × 4.6 mm, Agilent Technologies) equipped with an EC-C18 Guard cartridge (Agilent Technologies) at 22 °C. The mobile phase consisted of buffer A (25 mM NaH 2 PO 4 ) and buffer B (100% acetonitrile). Pump control and peak integration was achieved using the ChemStation software (Rev. A.10.02, build 1757, Agilent Technologies). Samples were analysed at 2 ml min −1 flow rate with the following buffer A/B gradient: 7.5 min 95%/5%, 0.5 min 90%/10%, 2 min 10%/90%, 1 min 95%/5%. Retention times of the individual nucleosides was determined with synthetic standards (3.2 min for adenosine (A), 5.8 min for 2′-O-methyladenosine (A m ), 5.9 min for N 6 -methyladenosine (m 6 A), 7.9 min for N 6 ,2′-O-dimethyladenosine (m 6 A m ). Guanosine was used as an internal control. After normalization of each peak area to the area of the guanosine peak area, the relative and absolute amount of individual nucleotides in each sample was determined based on the sequence of the input oligonucleotide. Sample preparation for mass spectrometry. m 6 A m demethylation intermediates were generated essentially as described previously 13 , with the difference that all reactions were carried out at 37 °C. Capped oligonucleotides were incubated with 100 nM FTO for 10 min at 37 °C followed by digestion with 2 units of P1 nuclease for an additional 15 min. Notably, P1 nuclease does not cleave the triphosphate linker of the cap and thus specifically releases the m 7 Gpppm 6 A m dinucleotide, while digesting the RNA backbone down to single nucleotides. To preserve the unstable demethylation intermediates 13 , the nucleotide mixture was immediately frozen in liquid nitrogen until further analysis. Detection of demethylation intermediates by mass spectrometry. FTO reaction products were extracted by cold 80% methanol:H 2 O at 1:20 volume ratio. After removal of precipitated protein, 4 μl of supernatant was injected into LC/MS for accurate mass measurement of demethylation intermediates. The LC/MS-MS system comprised an Agilent Model 1260 Bio-inert infinity liquid chromatography system coupled to an Agilent iFunnel 6550 quadrupole time-of-flight mass spectrometer. Chromatography of the reaction products was performed using aqueous normal phase (ANP) gradient separation, on Cogent Diamond Hydride (ANP) column (2.1 × 150 mm, 3.5 μm particle size; Microsolv Technology Corp). A precolumn filter (0.5 μm, Microsolv) was placed in front of the ANP column, to prevent column clogging. Mobile phases consisted of: (A) 50% isopropanol, containing 0.025% acetic acid; and (B) 90% acetonitrile containing 5 mM ammonium acetate. To eliminate the interference of metal ions on the chromatographic peak integrity and electrospray ionization, EDTA was added to the mobile phase at a final concentration of 6 μM. The following gradient was applied: 0-1.0 min, 99% B; 1.0-15.0 min, to 20% B; 15.0-29.0 min, 0% B; 29.1-37 min, 99% B. To minimize potential salt and other contaminants in the ESI source, a time segment was set to direct the first 0.5 min of column elute to waste.
Negative ion mass spectra in both profile and centroid mode were acquired in 2 GHz (extended dynamic range) mode, scanned at 1 spectrum per second over a mass/charge range of 20-1,000 Daltons. The QTOF capillary voltage was set 3,500 V and the fragmentor was set to 140 V. The nebulizer pressure was 35 p.s.i. and the nitrogen drying gas was 200 °C, delivered at a flow rate of 14 l min . Raw data was analysed with Agilent MassHunter Qualitative Analysis software (version B6.0). Profile data was used to provide measured mass. Cell culture and animals. HEK 293T/17 (ATCC CRL-11268; passage number 3-10; no further verification of cell line identity was performed) cells were maintained in DMEM (11995-065, ThermoFisher Scientific) with 10% FBS and antibiotics (100 units ml −1 penicillin and 100 μg ml −1 of streptomycin) under standard tissue culture conditions. Cells were split using TrypLE Express (Life Technologies) according to the manufacturer's instructions. Mycoplasma contamination in cells were routinely tested by Hoechst staining. To obtain embryonic day (E) 14 Ftoknockout mouse embryos and livers, Fto-knockout mice were bred as previously described 27 . Only male animals were used in the current study. All experiments involving mice were approved by the Institutional Animal Care and Use Committee at Weill Cornell Medical College. Antibodies. Antibodies used for western blot analysis or immunostaining were as follows: rabbit anti-DDDDK/Flag (ab1162, Abcam), rabbit anti-FTO (ab124892, Abcam), rabbit anti-GAPDH (ab9485, Abcam), mouse anti-ALKBH5 (ab69325, Abcam), mouse β-actin (A2228, Sigma) and goat anti-rabbit IgG Alexa Fluor 546 (A11035, ThermoFisher Scientific). For m 6 A individual-nucleotide-resolution cross-linking and immunoprecipitation (miCLIP), rabbit anti-m 6 A (ab151230, Abcam) was used. An in-house-generated rabbit anti-DCP2 serum was used for detection of DCP2. Knockdown and overexpression studies in HEK293T cells. FTO and ALKBH5 knockdown experiments were carried out in HEK293T cells using either Pepmute transfection reagent (Signagen) or Lipofectamine RNAiMAX (ThermoFisher Scientific) with 20 nM dsiRNA duplex directed against FTO (HSC.RNAI. N001080432.12.1, Integrated DNA Technologies) or 50 nM Silencer Select siRNA duplex pool targeting ALKBH5 (s29686, s29687, s29688, ThermoFisher Scientific), respectively. Scrambled siRNA was used as non-targeting control.
FTO and ALKBH5 expression experiments were carried out in HEK293T cells using LipoD293 transfection reagent (Signagen) with Flag-tagged full length human wild-type FTO, human wild-type FTO containing a Flag tag and two nuclear export signals (NES) at the N terminus, GST-tagged ALKBH5 lacking 66 N-terminal amino acids, or respective control vectors.
Cells were maintained at 70-80% confluency and harvested 48-72 h after the transfection. Knockdown and overexpression were confirmed by western blot. Total RNA was isolated using TRIzol (ThermoFisher Scientific) according to the manufacturer's instructions. If indicated, two rounds of poly(A) mRNA enrichment from total RNA was carried out with oligo d(T)25 Magnetic Beads (NEB) according to the manufacturer's instructions. Immunostaining of HEK293T cells. HEK293T cells transfected with either Flagtagged full-length human wild-type FTO or human wild-type FTO containing two nuclear export signals (NES) at the N terminus were grown on cover slips coated with poly-d-lysine, fixed with 4% paraformaldehyde in PEM buffer (80 mM potassium PIPES, 5 mM EGTA, 2 mM MgCl 2 , pH 7.0) for 10 min and permeabilized with 0.5% Triton X-100 in PEM buffer for 30 min. After blocking with 1% BSA in TBS-T for 1 h, cells were incubated with anti-DDDDK/Flag antibody (1:1,000 dilution in 1% BSA TBS-T) for 2 h followed by incubation with a goat anti-rabbit IgG antibody (1:1,000 dilution in 1% BSA TBS-T) for 1 h. Nuclei were stained with DAPI. All immunostaining steps were carried out at room temperature. Image acquisition was carried out on a Nikon Eclipse Ti microscope (Nikon), using NIS-Elements AR software (Version 3.2) . Generation of DCP2 CRISPR knockout cells. DCP2-knockout cell lines were generated by CRISPR/Cas9 technology using two guide RNAs (gRNAs; 5′-UAUCAAAGACUAUAUUUGUA-3′ and 5′-AACCAGUUUCUUCAAAG ACC-3′) designed to target the DCP2 genomic region corresponding to its catalytic site. Double-stranded DNA oligonucleotides corresponding to the gRNAs were inserted into the pSpCas9n(BB)-2A-Puro vector (Addgene). Equal amounts of the two gRNA plasmids were mixed and transfected into HEK293T cells using FuGENE 6 (Promega). The transfected cells were then subject to puromycin selection for three days and viable cells were used for serial dilution to generate single-cell clones. The genomic modification was screened by PCR and sequencing. In DCP2-knockout line 1, the two alleles were disrupted to generate out-of-frame mutation after V145 and I153, respectively. Line 2 contained a 55 nt homozygous deletion that removed the splicing site between intron 4 and exon 5. Line 3 contained one allele with a 194 nt deletion that removed the splicing site between intron 4 and exon 5, and the other allele was disrupted to generate out-of-frame mutation after V145. Loss of DCP2 protein expression was confirmed by western blot with in-house-generated anti-DCP2 sera 37 . Protein expression and purification. N-terminal HIS-tagged human FTO was generated by standard PCR-based cloning strategy and its identity was confirmed by sequencing FTO as described previously 4 , with minor modifications. FTO was overexpressed in E. coli BL21 Rosetta (DE3) using pET-28(+) (Novagen). Cells expressing FTO were induced with 0.5 mM isopropyl β-d-1-thiogalactopyranoside (IPTG) for 16 h at 18 °C. Cells were collected, pelleted and then resuspended in buffer A (50 mM NaH 2 PO 4 pH 7.2, 300 mM NaCl, 20 mM imidazole-HCl pH 7.2, 5 mM β-mercaptoethanol). The cells were lysed by sonication and then centrifuged at 10,000g for 20 min. The soluble proteins were purified using Talon Metal Affinity Resin (Contech) and eluted in buffer B (50 mM NaH 2 PO 4 pH 7.2, 300 mM NaCl, 250 mM imidazole-HCl pH 7.2, 5 mM β-mercaptoethanol). Further concentration and purification was performed using Amicon Ultra-4 spin columns (Merck-Millipore). Recombinant protein was stored in enzyme storage buffer (20 mM HEPES pH 8.0, 50 mM NaCl, 10% glycerol) at −80 °C. All protein purification steps were performed at 4 °C. , with some modifications. Poly(A) RNA (1 μg) was used for the assay. Free 5′-OH ends were phosphorylated using 30 units of T4 polynucleotide kinase (PNK, NEB) and 1 mM ATP, according to the manufacturer's instructions. 5′ phosphorylated RNA fragments were digested with 2 units of Terminator 5′-Phosphate-Dependent Exonuclease (Epicentre). Capped RNAs are unaffected by this treatment. After phenol-chloroform extraction and ethanol precipitation, RNA samples were resuspended in 10 μl of DEPC-H 2 O and 400 ng of the RNA was decapped with 25 units of RppH (NEB) for 3 h at 37 °C. The 5′ phosphates of the exposed cap-adjacent nucleotide were removed by the addition of 5 units of rSAP (NEB) and further incubated for 30 min at 37 °C. Up to this point, all enzymatic reactions were performed in the presence of SUPERase In RNase Inhibitor (ThermoFisher Scientific). After phenol-chloroform extraction and ethanol precipitation, RNA samples were resuspended in 10 μl of DEPC-H 2 O and 5′ ends were labelled using 30 units T4 PNK and 0.8 mBq [γ-32 P] ATP at 37 °C for 30 min. PNK was heat inactivated at 65 °C for 20 min and the reaction was passed through a P-30 spin column (Bio-Rad) to remove unincorporated isotope. 10 μl of labelled RNA were then digested with 4 units of P1 nuclease (Sigma) for 3 h at 37 °C. 4 μl of the released 5′ monophosphates from this digest were then analysed by 2D TLC on glass-backed PEI-cellulose plates (MerckMillipore) as described previously A m :A m ratio was calculated. The use of this ratio has been described previously 14 . We confirmed that this assay is linear by spotting twice the sample material and confirming that the signal intensity doubles for the unmodified nucleotides (A, C and U). Furthermore, exposure time of the TLC plates to the phosphor screen was chosen so that the signal was not saturated. In brief, 10 nM recombinant DCP2 protein was incubated with the indicated cap-labelled RNAs in decapping buffer (10 mM Tris-HCl pH 7.5, 100 mM KCl, 2 mM MgCl 2 , 2 mM DTT, 0.5 mM MnCl 2 , 40 U ml −1 recombinant RNase inhibitor) and incubated at 37 °C for 30 min. Reactions were stopped with 25 mM EDTA at the indicated time points. The identity of decapping products of the indicated modified cap adenosines subjected to 20 nM recombinant human DCP2 protein at 37 °C for 30 min were confirmed to be m 7 GDP by treatment with 0.5 U nucleoside diphosphate kinase (NDPK) at 37 °C for 30 min in the presence of 0.5 mM ATP. A cap labelled RNA with a guanosine as the first nucleotide generated as previously described 38 was used as a positive control. Decapping products were resolved by PEI-cellulose TLC plates (Sigma-Aldrich) and developed in 0.45 M (NH 4 ) 2 SO 4 in a TLC chamber at room temperature. Reaction products were visualized and quantitated with a Molecular Dynamics PhosphorImager (Storm860) with ImageQuant-5 software. A m , we used thermostable TGK polymerase 39 , which enables RNA synthesis with an RNA primer from a DNA template. The primers contained either m 7 GpppA m or m 7 Gpppm 6 A m as the extended cap. The use of TGK polymerase and specific methylated forms of the primer ensures that all synthesized mRNAs begin with the desired extended cap structure. The DNA template for RNA synthesis was prepared by PCR using the pNL1.1[Nluc] vector (Promega) as a template and Phusion High-Fidelity PCR Master Mix (NEB). Since the template needs to be single-stranded, we used a strategy of selectively degrading one of the strands of the PCR product. To achieve this, PCR was performed with a 5′-phosphorylated forward primer and a 5′-OH reverse primer. The undesired 5′-phosphorylated strand was digested with lambda exonuclease (Lucigen) (1 U per 1-2 μg double-stranded DNA) for 2 h at 37 °C. The digestion was stopped by phenol chloroform extraction and ethanol precipitation of the single-strand template.
RNA forward synthesis was performed from either an m A m (20 nt) primer in a 50 μl reaction consisting of 1 × Thermopol buffer (NEB) supplemented with 3 mM MgSO4 and 2.5 mM NTP with a 1:1 primer/ template ratio at 100 pmol each and 150 nM TGK polymerase. The primer extension was performed at two cycles of 10 s at 94 °C, 1 min at 50 °C, and 1 h at 65 °C. After RNA synthesis, the template DNA strand was degraded using TURBO DNase (Thermo Fisher Scientific) and the capped nLuc mRNAs were purified with an RNeasy column (Qiagen). An approximately 250 nt poly(A) tail was added with A-Plus Poly(A) Polymerase Tailing Kit (Cellscript). The polyadenylated mRNAs were purified with oligo d(T)25 Magnetic Beads (NEB) according to the manufacturer's instructions.
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A m -nLuc mRNAs into HEK293T cells, we used electroporation. HEK293T cells were trypsinized and resuspended in Ingenio Electroporation Solution (Mirus) at 5 × 10 6 cells ml −1
. 100 μl of cell suspension was added to 2 μg of mRNA. Electroporation was carried out with Nucleofector II (Amaxa) using program Q-001. The cell suspension was immediately transferred to 37 °C pre-warmed growth medium supplemented with 5 mM CaCl 2 and 200 U ml −1 micrococcal nuclease (Clontech). After a 15 min incubation period at 37 °C to remove any residual extracellular RNA, cells were transferred to 24-well plates at 1.25 × 10 5 and incubated until adherent. Cells were then either collected immediately or after 2 h of incubation for RNA extraction and quantification by qRT-PCR. RNA half-life measurement after transcriptional inhibition. RNA half-lives after transcriptional inhibition were determined essentially as previously described 40, 41 . In brief, to achieve transcriptional inhibition for calculation of mRNA half-life, Flag-and NES-FTO-transfected HEK293T cells were either left untreated (that is, 0 h time point) or treated with actinomycin D (Sigma) for 6 h at a final concentration of 5 μg ml −1
. Cells were then harvested for RNA isolation using TRIzol (Thermo Fisher Scientific). The total RNA derived from Flag-and NES-FTOtransfected HEK293T cells, was spiked-in with ERCC RNA controls (Ambion) before the isolation of mRNA and RNA-seq (see below). Read count tables were generated using STAR aligner 42 . DESeq2
43 was used to calculate ERCC spike-in RNA size factors, which were then applied to normalize for library size changes in each replicate. As shown in Extended Data Fig. 6c , the half-lives derived from the transcriptional inhibition experiments showed high correlation between independent replicates. RNA half-life measurements by 5-bromouridine (BrU) pulse-chase. RNA halflife measurements by BrU pulse-chase was carried out essentially as described previously 44 . Briefly, HEK293T cells were pulsed with 150 μM 5-bromouridine (Santa Cruz Biotechnology) for 24 h. Chase was initiated by changing to medium containing 1.5 mM uridine (Sigma) and cells were collected for RNA extraction after 6 and 16 h. BrU-pulsed cells without uridine-chase were used as basal (0 h) controls. Total RNA was extracted with TRIzol reagent (Thermo Fisher Scientific) according to the manufacturer's instructions. Immunoprecipitation of BrU-labelled RNA from total RNA was carried out as previously described 44 . A BrU-labelled NanoLuc luciferase (nLuc) RNA was generated by in vitro transcription as previously described 44 and used as a spike-in immunoprecipitation control at 10 pgp per 1 μg input RNA. Quantitative real-time PCR. 1-2 μg total RNA or 500 ng BrU-labelled RNA was reverse transcribed using the High Capacity cDNA Kit (Thermo Fisher Scientific) according to the manufacturer's instructions. The cDNA was subjected to quantitative real-time PCR analysis with the TaqMan Gene Expression Master Mix (Thermo Fisher Scientific) using Taqman Gene Expression Assays (Thermo Fisher Scientific) on a ViiA 7 Realtime-PCR System (Thermo Fisher Scientific). The following predesigned Taqman Gene expression assays were used in the current study:
ACTB (Hs01060665_g1) was used as a housekeeping gene to normalize the level of transfected nLuc mRNA. A custom probe and primer set was designed to detect nLuc cDNA (forward 5′-ATGTCGATCTTCAGCCCATTT-3′; reverse 5′-GGA GGTGTGTCCAGTTTGTT-3′; probe 5′-/56-FAM/ATCCAAAGGATTGTC CTGAGCGGT/3IABkFQ/-3′). Amplification of nLuc cDNA was linear over seven orders of magnitude. The −∆∆
2
Ct method was used to calculate relative gene expression changes between time points and biological replicates. m 6 A peak enrichment analyses. m 6 A peaks were based on our previous MeRIPseq analysis of Fto-knockout midbrain tissue 11 . For analysis of m 6 A peak distribution, m 6 A peaks were individually binned based on their location within mRNA and mapped onto a virtual transcript in a metagene analysis to show their collective distribution within mRNA. Bin numbers were chosen such that each bin is on average 50 nucleotides long. Peak counts were smoothed using a spline function. We weighted each peak by a coefficient corresponding to the number of MeRIP-seq reads in the immunoprecipitated samples relative to the reads obtained before immunoprecipitation. This peak mass value represents the enrichment of methylated mRNA at individual m 6 A sites after immunoprecipitation and reflects the degree to which an mRNA is methylated at a particular m 6 A site. To generate the peak height ratio plot, we used ratios between Fto-knockout peak mass over wild-type peak mass. The same bin numbers and sizes were used for all analyses. A m sites, we used the miCLIP pipeline 12 with the following modifications. Raw miCLIP reads were trimmed of their 3′ adaptor and demultiplexed as previously described 12 . Then, PCR-duplicated reads of identical sequences were removed using the pyDuplicateRemover.py script of the pyCRAC tool suite (version 1.2.2.3). Unique reads were mapped with Bowtie (version 1.1.1) to hg19. Files of aligned reads were processed with samtools (version 1.2), bedtools (version 2.25.0), and custom bash commands to derive the 5′ ends of each aligned read. 5′-end coordinates of the reads were then combined into 'piles' at each single nucleotide throughout the genome using the tag2cluster.pl script of the CIMS software package 45 (parameters: -v -s -maxgap "-1"). Piles were then filtered to contain at least five 5′ ends at a single nucleotide. Adjacent piles (zero nucleotides apart) were clustered together using a custom perl script. The resulting clusters were annotated with their transcript ID and transcript region (5′ UTR, CDS, or 3′ UTR) using a custom perl script and custom bash commands. After annotation, clusters were filtered for those found in the 5′ UTR of annotated mRNAs. To remove noise, clusters with a width of one nucleotide were removed using custom bash commands. Finally, custom bash commands were used to filter for clusters found only at the very beginning of 5′ UTRs.
To verify that these are indeed m , a custom perl script was used. The CAGE sites in this data set are combined from RLE (relative log expression)-normalized robust CAGE-seq analysis of multiple cell lines and tissues, and therefore provide high sensitivity for detecting transcription start sites.
We then determined the distribution of TSS or the YYANW sequence around m A individual-nucleotide-resolution cross-linking and immunoprecipitation (miCLIP) data set in HEK293T cells 12 . Metagenes were constructed for the miCLIP-identified unique 6mA reads using an in-house perl annotation pipeline and custom R scripts. Briefly, the 6mA reads were mapped to different RNA features (5′ UTR, CDS and 3′ UTR) of the human genome (hg19). Position of the reads was normalized to the median feature length of the RNAs to which the tag mapped. A frequency distribution plot was generated by counting number of reads in contiguous bins on a virtual mRNA transcript, whose feature lengths represent the median feature lengths of RNAs under analysis either of each individual sample or of the control sample. A kernel density (Gaussian) estimate was plotted. RNA-seq analysis. To avoid potential clonal variation, 10 6 cells from each of the three DCP2 CRISPR lines were pooled together (referred to as DCP2-knockout cells), passaged once, and immediately used for RNA-seq. The DCP2 CRISPR line RNA samples were subject to depletion of ribosomal RNA using RiboMinus Eukaryote System v.2 (Life Technologies), followed by cDNA library preparation using the Illumina TruSeq RNA Sample Preparation Kit v.2. The sequencing (2 × 100-bp paired-end) was performed by RUCDR Infinite Biologics (Piscataway) using the Illumina Hiseq 2500 according to the manufacturer's protocol. Two independent biological replicates were sequenced for each condition. The RNA-seq library for miCLIP normalization (see 'Mapping and validation of m 6 A m sites') was prepared using a cloning strategy parallel to the one used in miCLIP 12, 49 . For all other RNA-seq analyses, total RNA was diluted to a concentration of 50 ng μl −1 and submitted to the Weill Cornell Medicine Epigenomics Core for isolation of mRNA and library preparation using the Illumina TruSeq Stranded mRNA Library Prep Kit (RS-122-2101, Illumina). The libraries were sequenced on the Illumina HiSeq 2500 instrument, in either single-read or paired-end mode, with 50-100 bases per read. At least two independent biological replicates were sequenced for each condition.
Gene expression was measured using STAR 42 read counts (version 2.4.1; -quantMode TranscriptomeSAM GeneCounts), which were processed with either the DESeq2 pipeline 43 (version 1.8.1) or the RSEM pipeline 50 (version 1.2.25). Analysis and visualization of RNA-seq datasets was carried out with custom in-house-generated R scripts using RStudio (Version 0.99.489). Only transcripts with normalized read counts >1 were included in the analyses.
Previously published RNA-seq datasets used in the current study were extracted from Gene Expression Omnibus (GEO, NCBI) and, if no processed data was available, the fastq files were reanalysed with the pipelines described above. mRNA half-life data was either calculated based on the decay rates derived from our own HEK293T cell data set or was extracted from previously published half-life data sets in HeLa cells 40 . Only mRNAs with a half-life between 0 h and 25 h were used in our analysis of mRNA half-life based on the identity of the first encoded nucleotide. For classification of short-and long-lived mRNAs, half-life values were divided into quartiles. mRNAs in the lowest quartile (0-3 h) were defined as short-lived, whereas mRNAs in the highest quartile (10-24 h) were defined as long-lived. The analysis of DICER-and AGO2-knockdown effects on m 6 A m mRNAs was performed using previously published datasets 20 . We used m 6 A m mapped in mouse liver 12 in order to correspond with the mouse liver expression analysis in these datasets. When indicated, we limited the analysis to mRNAs with TargetScan-predicted microRNA-binding sites and a context score cut-off ≤0.1 (ref. 51). Non-target mRNAs in Extended Data Fig. 9f were filtered for mRNAs that contain 3′ UTR sizes ≤300 nt to reduce the likelihood of analysing mRNAs with alternative 3′ UTRs or alternative polyadenylation sites. The analysis of the effect of single microRNA transfection on m 6 A m mRNAs was performed using previously published datasets of miR-155 duplex transfected HeLa cells 21 . In these experiments, we limited the analysis to CLIP-supported microRNA-mRNAs interactions according to starBase v.2.0 52 .
Ribosome profiling. To determine if m 6
A m is associated with changes in translation efficiency, we analysed a previously published ribosome profiling dataset 53 . Ribosome footprint reads and corresponding RNA-seq reads were processed essentially as described 54 . First, adaptors were trimmed using Flexbar v.2.5. For ribosome footprints, only reads from which the adaptor was trimmed were retained. Reads mapping to ribosomal RNAs were removed with bowtie v.1.1.2. Remaining reads were then aligned to the hg19 genome with STAR v.2.5.2a in a splicing-aware manner and using UCSC refSeq as a transcript model database (version from 2 June 2014 downloaded from Illumina iGenomes). Two mismatches were allowed and only unique alignments were reported. Aligned reads were then counted on transcript regions using custom R scripts considering only transcripts with annotated 5′ and 3′ UTRs. Translation efficiency was calculated as previously described 21 , with pre-filtering for transcripts that had at least ten counted reads. Statistics and software. P values were calculated with a two-tailed unpaired Student's t-test or, for the comparison of more than two groups, with a one-or two-way ANOVA followed by Bonferroni's or Tukey's post hoc test. Reproducibility of half-life and translation efficiency measurements was assessed by calculating the Pearson correlation coefficient between replicates. The influence of covariates on the effect of m 6 A m -containing mRNAs compared to non-m 6 A m mRNAs on mRNA half-life was studied by ANCOVA analysis using SPSS Statistics software (IBM, v.22). The covariates include the number of mRNA-destabilizing AU-rich, GU-rich and U-rich elements 55 , gene expression (log 2 [FPKM] , FPKM >1), translation efficiency (log 2 [TE], TE > 0), GC composition and length of 5′ and 3′ UTR, number of exons in 5′ and 3′ UTRs, number of conserved miRNA target sites (P CT > 0) 56 , minimumfree energy to length ratio 57 , and the number of G-quadruplexes in the 5′ UTR 58, 59 . GC composition, UTR lengths, and the number of exons were calculated from refseq mRNA annotations (hg19) from the UCSC Genome browser. P values of 0.05 or less were considered significant. Initial reaction velocities for enzyme kinetics were analysed by nonlinear regression curve-fitting using Graphpad Prism software (version 5.0f) to obtain k cat , K m and V max . Gene Ontology (GO) functional annotation was performed using PANTHER Overrepresentation Test (release 20150430) and Bonferroni correction with a P value threshold of <0.01. Non-m 6 A m -containing mRNAs were used as the background gene list. Code availability. The custom Perl and R scripts used in this study are available on request from the corresponding author (S.R.J.). Data availability. Sequencing data that support the findings of this study have been deposited in the GEO database under accession number GSE78040. A summary of all the data sets used in the current study can be found in Supplementary  Table 6 . 
